TNFRSF9 and neoplasm: In summary, our results support the notion that proper activation of cytotoxic T cells is critical in tumor control, and a combination of iv nanoparticle vaccination and anti-PD-1 or anti-4-1BB antibody treatments leads to more durable tumor control.